๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—†
Updated 04 Jul 2026 ยท HPRA open data

Lacosamide - Medicines in Ireland

30 authorised products containing Lacosamide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 30 authorised medicines
MedicineActive substanceLicence holderStatus
10 mg/ml Solution for infusion
EU/1/19/1383/001-002
Lacosamide UCB Pharma S.A. โ€”
Lacosamide Accord 10 mg/ml solution for infusion
EU/1/17/1230/026-027
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 100 mg film coated tablets
EU/1/17/1230/005-008
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 150 mg film coated tablets
EU/1/17/1230/009-012
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 200 mg film coated tablets
EU/1/17/1230/013-016
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Accord 50 mg film coated tablets
EU/1/17/1230/001-004
Lacosamide Accord Healthcare S.L.U. โ€”
Lacosamide Adroiq 10 mg/ml solution for infusion
EU/1/23/1732/001
Lacosamide Extrovis EU Kft. โ€”
Lacosamide Ascend 10 mg/ml syrup
PA23429/001/001
Lacosamide Ascend GmbH Not marketed
Lacosamide Fresenius Kabi 10 mg/ml solution for infusion
PA2059/078/001
Lacosamide Fresenius Kabi Deutschland GmbH Not marketed
Lacosamide Grindeks 100 mg film-coated tablets
PA22992/026/002
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 150 mg film-coated tablets
PA22992/026/003
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 200 mg film-coated tablets
PA22992/026/004
Lacosamide AS Grindeks Not marketed
Lacosamide Grindeks 50 mg film-coated tablets
PA22992/026/001
Lacosamide AS Grindeks Not marketed
Lacosamide Krka 100 mg film-coated tablets
PA1347/099/002
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 150 mg film-coated tablets
PA1347/099/003
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 200 mg film-coated tablets
PA1347/099/004
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 50 mg film-coated tablets
PA1347/099/001
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide UCB 10 mg/ml Syrup
EU/1/19/1383/003
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 100 mg Film-coated tablet
EU/1/19/1383/010-015
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 150 mg Film-coated tablet
EU/1/19/1383/016-021
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 200 mg Film-coated tablet
EU/1/19/1383/022-027
Lacosamide UCB Pharma S.A. โ€”
Lacosamide UCB 50 mg Film-coated tablet
EU/1/19/1383/004-009
Lacosamide UCB Pharma S.A. โ€”
Vimpat 10 mg/ml solution for infusion
EU/1/08/470/16
Lacosamide UCB Pharma S.A. โ€”
Vimpat 10 mg/ml syrup
EU/1/08/470/018-019
Lacosamide UCB Pharma S.A. โ€”
Vimpat 100 mg film-coated tablets
EU/1/08/470/4-6
Lacosamide UCB Pharma S.A. โ€”
Vimpat 15 mg/ml syrup
EU/1/08/470/14-15
Lacosamide UCB Pharma S.A. โ€”
Vimpat 150 mg film-coated tablets
EU/1/08/470/7-9
Lacosamide UCB Pharma S.A. โ€”
Vimpat 200 mg film-coated tablets
EU/1/08/470/10-12
Lacosamide UCB Pharma S.A. โ€”
Vimpat 50 mg film-coated tablets
EU/1/08/470/1-3
Lacosamide UCB Pharma S.A. โ€”
Vimpat 50mg/ 100mg/ 150mg film-coated tablets
EU/1/08/470/13
Lacosamide UCB Pharma S.A. โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.